🧬 biology

The clinical and molecular spectrum of AGO2-associated Lessel-Kreienkamp neurodevelopmental syndrome

This study expands the clinical and molecular understanding of Lessel-Kreienkamp syndrome by characterizing 45 new individuals with AGO2 variants, revealing a multisystemic neurodevelopmental disorder driven by diverse structural perturbations that disrupt specific AGO2 functions—including miRNA binding, P-body assembly, and phosphorylation-dependent turnover—thereby linking distinct molecular mechanisms to phenotypic variability.

Original authors: Debora Tibbe, Christina Kiel, Olena Ielesicheva, Kerstin Robles de Maruri, Helia Mahboobi, Joschka Züghart, Hans-Hinrich Hönck, Christoph Meier, Fabiola Biasella, Marcela Legue, Maria Francisca Lopez

Published 2026-07-02

📖 5 min read🧠 Deep dive

CC BY 4.0

Original authors: Debora Tibbe, Christina Kiel, Olena Ielesicheva, Kerstin Robles de Maruri, Helia Mahboobi, Joschka Züghart, Hans-Hinrich Hönck, Christoph Meier, Fabiola Biasella, Marcela Legue, Maria Francisca Lopez Avaria, Edward Blair, Tracy Lester, Benito Banos-Pinero, Jose Pulido, Adele Schneider, Rebecca Procopio, Chloe Quelin, Bailey Leal, Julian Martinez-Agosto, Stephanie Bottomley, Agnes Till, Kinga Hadzsiev, Renata Szalai, Kathryn Weaver, Joel Fluss, Henri Margot, Berta Almoguera, Isabel Lorda-Sanchez, Lucia Lopez-Lopez, Austin Hamm, Himanshu Goel, Yasemin Alanay, Özlem Akgün Dogan, Gülşah Şebnem Özköse-İyigel, Genevieve Baujat, Marion Lesieur, Sophie Rondeau, Katherine Schon, Joseph Christopher, Bertrand Isidor, Benjamin Cogne, Neena Agrawal, Ryan Dahlhauser, Yutaka Furuta, Rachel Rabin, John Pappas, Chirag Patel, Irma Järvela, Merja Rauhala, Isabelle Schrauwen, Suzanne Leal, Siddharth Banka, Celine Prebel-Richard, Fanny Laffargue, Nelly Durand, Tristan Celse, Maja Hempel, Ilia Valentin, Andrea Gregorova, Lenka Noskova, Sara Baumgartner, Christa Überbacher, Kai Muru, Ülle Murumets, Stella Lilles, Katharina Steindl, Anita Rauch, Federica Ruscitti, Alain Verloes, Jonathan Levy, Joohyun Park, Tobias Haack, Ingrid Bader, Sophie Julia, Guillaume Banneau, Alison Muir, Davor Lessel, Hans-Jürgen Kreienkamp

Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). ⚕️ This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer

The Big Picture: A Broken "Editor" in the Brain

Imagine your body's cells are like a busy newsroom. Every day, they produce thousands of articles (proteins) based on instructions from a master blueprint (DNA). However, not every article needs to be printed. Some are outdated, some are wrong, and some just need to be edited down.

To manage this, the cell uses a sophisticated editing team called RISC (RNA-induced silencing complex). The star editor of this team is a protein called AGO2. Its job is to read "guide notes" (microRNAs) and find the specific articles that need to be deleted or silenced so the cell doesn't get cluttered with the wrong stuff.

This paper is about a condition called Lessel-Kreienkamp syndrome (LESKRES). It happens when the AGO2 gene has a typo (a mutation), making the "editor" protein defective. When the editor can't do its job, the cell gets confused, leading to problems with brain development and other body systems.

What the Researchers Did

The researchers gathered a massive team of doctors and scientists from around the world to study 70 people with this syndrome. They found 33 different typos in the AGO2 gene, 30 of which had never been seen before.

They didn't just look at the patients; they also went into the lab to see exactly how these typos broke the "editor" protein. They treated the protein like a machine, testing its gears, its ability to grab onto things, and how it moved.

The Symptoms: A "Neurodevelopmental" Mix

The paper describes a very consistent pattern of symptoms in these 70 individuals. If you imagine the brain as a construction site, the workers are confused and slow.

The Core Trio: Almost everyone (97%) had trouble learning to speak, had intellectual disabilities, and were slow to learn motor skills (like walking or crawling).
The "Extra" Features: About two-thirds had low muscle tone (floppy muscles). Many had autism-like traits or ADHD. Some had seizures, heart issues, or unusual facial features (like a thin upper lip or wide-set eyes).
The Surprise: The severity varied wildly. Some children were severely affected, while others were much milder. One child even had breathing trouble as a newborn but later developed normally, suggesting the body can sometimes compensate.

The Lab Findings: How the "Editor" Broke

The researchers tested the broken AGO2 proteins to see how they failed. They found that the typos didn't all break the machine in the same way. Here are the main ways the "editor" failed:

1. The "Glue" Problem (P-Body Assembly)
Normally, the editor protein gathers with other helpers in specific "workshops" inside the cell called P-bodies to do its job.

The Finding: One specific typo (p.Asp619Asn) broke the "glue" that holds the editor to its helpers. Without this glue, the editor couldn't get into the workshop, and the workshop itself fell apart.
The Result: This specific mutation caused a milder form of the disease, suggesting that when the editor is completely lost, the body might have other ways to cope.

2. The "Recycling" Problem (Phosphorylation)
After the editor finishes deleting an article, it needs a "stamp" (phosphorylation) to let go and go find the next one.

The Finding: Several typos prevented the editor from getting this stamp. It got stuck holding onto the wrong articles, unable to let go and move on.
The Result: The editing process slowed down, causing a backlog of bad instructions in the cell.

3. The "Guide Note" Problem (miRNA Binding)
The editor needs to hold onto its "guide notes" (microRNAs) tightly to know what to delete.

The Finding: Some typos, especially those near a specific hinge in the protein (like p.Phe182del), made the editor drop its guide notes or hold them too loosely.
The Result: The editor started grabbing the wrong notes or the wrong ends of the notes. This led to a chaotic mix of "isomiRs" (slightly messed-up versions of the guide notes), causing the cell to delete the wrong things.

The "Hotspots"

The researchers noticed that the typos weren't random. They clustered in specific "hotspots" on the protein, like the L1 loop, Helix-7, and the PIWI domain.

Analogy: Imagine a car engine. If you break the spark plug, the car won't start. If you break the fuel pump, it won't run. Even though the result (a broken car) is the same, the part that broke is different.
The Paper's Claim: These hotspots are critical structural areas. Breaking them disrupts the engine in different ways, but they all lead to the same outcome: a broken brain development process.

The Takeaway

This paper expands our understanding of Lessel-Kreienkamp syndrome in two big ways:

Clinically: It confirms that this is a complex condition affecting the brain, behavior, and body, with a wide range of severity. It's not just one thing; it's a spectrum.
Molecularly: It shows that there isn't just one way to break the AGO2 protein. Some typos stop the protein from moving, some stop it from holding its tools, and some stop it from letting go of its work.

Crucially, the paper states: Even though we now know how these proteins break, we still cannot perfectly predict which specific typo will cause a mild or severe case in a specific person. The body's "backup systems" and other genetic factors seem to play a huge role in the final outcome.

In short: The AGO2 protein is a vital editor for our cells. When it breaks, the brain's construction site gets messy. This paper maps out exactly where the breaks happen and how they mess up the editing process, helping us understand why this syndrome looks so different in different people.